A

Anokion

38 employees

Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Protein engineering
Biologics
Therapeutics
Immunoengineering
Autoimmune diseases
Clinical Trials

Date founded

2010

Funding rounds raised

Total raised

$40M

from 2 investors over 2 rounds

A

Anokion raised $40M on September 11, 2019

Investors: Celgene

A

Anokion raised $38M on May 9, 2014

Investors: Versant Ventures

FAQ